| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/23/1994 | WO1994013697A1 Treatment of septic shock with conjugated biologically active peptides |
| 06/23/1994 | WO1994013696A1 Spiro piperidines and homologs which promote release of growth hormone |
| 06/23/1994 | WO1994013695A1 Dolostatin analog |
| 06/23/1994 | WO1994013693A1 NOVEL INHIBITORS OF FACTOR Xa |
| 06/23/1994 | WO1994013692A1 Polypeptides useful for treating inflammatory disorders |
| 06/23/1994 | WO1994013688A1 Dna-armed ribozymes and minizymes |
| 06/23/1994 | WO1994013687A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 06/23/1994 | WO1994013684A1 Novel substance dolastatin c and pharmaceutical use thereof |
| 06/23/1994 | WO1994013682A1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
| 06/23/1994 | WO1994013329A1 Process for preparing a virus-safe biological composition |
| 06/23/1994 | WO1994013322A1 Improved synthesis of polymer bio-active conjugates |
| 06/23/1994 | WO1994013321A1 Suppression of myeloid cells |
| 06/23/1994 | WO1994013320A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease |
| 06/23/1994 | WO1994013319A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
| 06/23/1994 | WO1994013318A1 Protein preparation for the prevention and therapy of periodontitis or other bacterial pathologies of the oral cavity |
| 06/23/1994 | WO1994013317A1 Sustained-release preparation |
| 06/23/1994 | WO1994013316A1 Potent and specific chemically-conjugated immunotoxins |
| 06/23/1994 | WO1994013315A1 A novel eukaryotic transcription protein: host cell factor |
| 06/23/1994 | WO1994013314A1 Combination for treating hiv infections containing thymosine, interleukin and hiv replication or reverse transcriptase inhibitors |
| 06/23/1994 | WO1994013313A1 6-position modified decapeptide lhrh antagonists |
| 06/23/1994 | WO1994013312A1 Mucosal vascular addressin, dna and expression |
| 06/23/1994 | WO1994013311A1 Glycolipid enzyme-polymer conjugates |
| 06/23/1994 | WO1994013310A1 A bone sialoprotein binding protein as well as its preparation |
| 06/23/1994 | WO1994013275A1 Glaucoma treatment |
| 06/23/1994 | WO1994013265A1 A free radical quenching liposomal composition |
| 06/23/1994 | WO1994013264A1 Clostridial toxin disease therapy |
| 06/23/1994 | WO1994013143A1 Stabilized lanthionine bacteriocin compositions |
| 06/23/1994 | WO1994009126A3 Acyl coenzyme a: cholesterol acyltransferase (acat) |
| 06/23/1994 | WO1994004184A3 Method of decreasing cutaneous senescence |
| 06/23/1994 | CA2151953A1 "dolostatin analog" (novel peptides, the preparation and use thereof) |
| 06/23/1994 | CA2151927A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
| 06/23/1994 | CA2151909A1 Protein preparation for the prevention and therapy of periodontitis or other bacterial pathologies of the oral cavity |
| 06/23/1994 | CA2151496A1 Nucleotide sequence for treating cancer and infection |
| 06/23/1994 | CA2151495A1 A free radical quenching liposomal composition |
| 06/23/1994 | CA2151455A1 Delta-like gene expressed in neuroendocrine tumors |
| 06/23/1994 | CA2151387A1 Suppression of myeloid cells |
| 06/23/1994 | CA2151046A1 Treatment of septic shock with conjugated biologically active peptides |
| 06/23/1994 | CA2151044A1 Novel inhibitors for factor xa |
| 06/23/1994 | CA2150956A1 Glycolipid enzyme-polymer conjugates |
| 06/23/1994 | CA2150935A1 Clostridial toxin disease therapy |
| 06/23/1994 | CA2150909A1 Clotting inhibitor made from protostomia saliva |
| 06/23/1994 | CA2150536A1 Retroviral vectors for the treatment of tumors, and cell lines containing them |
| 06/23/1994 | CA2150249A1 Lymphotoxin-.beta., lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof |
| 06/23/1994 | CA2136078A1 6-position modified decapeptide lhrh antagonists |
| 06/23/1994 | CA2129436A1 Hematopoietic inhibiting factor containing compositions |
| 06/23/1994 | CA2112052A1 Inhibitors of hiv protease useful for the treatment of aids |
| 06/23/1994 | CA2112046A1 Antibodies, polypeptides, production and use thereof |
| 06/23/1994 | CA2112042A1 Inhibitors of hiv protease useful for the treatment of aids |
| 06/23/1994 | CA2112038A1 Inhibitors of hiv protease useful for the treatment of aids |
| 06/23/1994 | CA2110852A1 Monoclonal antibodies that define a unique antigen of human b cell receptor complex and methods of using same for diagnosis and treatment |
| 06/22/1994 | EP0603159A2 Human growth hormone formulation |
| 06/22/1994 | EP0603112A1 Use of thrombin inhibitors for inhibiting ocular fibrin formation |
| 06/22/1994 | EP0603031A2 Antiviral antibiotic BU-4724V and preparation thereof |
| 06/22/1994 | EP0603030A2 Antiviral antibiotic BU-4628V and preparation thereof |
| 06/22/1994 | EP0602688A1 Methionine free G-CSf from prokaryotes |
| 06/22/1994 | EP0602687A1 Modified VP1/P2A regions of rhinovirus systems |
| 06/22/1994 | EP0602686A2 Lectin concentrates of mistletoe extracts and corresponding standardized, stabilized mistletoe lectin preparations, process for their production as well as medicines containing them and their use |
| 06/22/1994 | EP0602306A1 Retroviral protease inhibitors |
| 06/22/1994 | EP0602297A1 Fish collection and elastin solutions |
| 06/22/1994 | EP0602211A1 Use of growth factor igf-ii |
| 06/22/1994 | EP0602210A1 Use of growth factor igf-i and/or igf-ii |
| 06/22/1994 | EP0602194A1 Peptide inhibitors of inflammation mediated by selectins |
| 06/22/1994 | EP0602178A1 T cell receptor-based therapy for rheumatoid arthritis |
| 06/22/1994 | EP0602173A1 Topical fibrinogen complex |
| 06/22/1994 | EP0602172A1 A method for treatment of patients with chronic liver disease |
| 06/22/1994 | EP0602157A1 Ribosomal structure derived from the genomic rna structure of the delta hepatitus virus |
| 06/22/1994 | EP0602144A1 Dna sequences encoding gelonin polypeptide |
| 06/22/1994 | EP0602127A1 Methods and compositions for modulating g protein action |
| 06/22/1994 | EP0602126A1 Immunoglobulin variants for specific fc epsilon receptors |
| 06/22/1994 | EP0602118A1 $i(IN VIVO) GENE TRANSFER USING IMPLANTED RETROVIRAL PRODUCER CELLS |
| 06/22/1994 | EP0602026A1 New organic derivative of a metal with a phospholipid structure, use of this derivative as a biomediator, process for isolating this derivative and pharmaceutical compositions containing it |
| 06/22/1994 | EP0547064B1 Protease resistant pdgf and methods of use |
| 06/22/1994 | EP0513072B1 Improved cyclodextrin based erythropoietin formulation |
| 06/22/1994 | EP0486525B1 Stabilized protein or peptide conjugates |
| 06/22/1994 | EP0470136B1 Therapeutic agent |
| 06/22/1994 | EP0413024B1 Protein having activity of inhibiting inflammation-inducing phospholipase a2 |
| 06/22/1994 | EP0177568B1 Recombinant dna molecules |
| 06/22/1994 | EP0176588B1 Platelet related growth regulator |
| 06/22/1994 | CN1088216A Modified platelet factor-4 |
| 06/22/1994 | CN1088210A Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| 06/22/1994 | CN1088095A Anti-cancer therapeutic compositions for prophylaxis or for treatment of cancer |
| 06/21/1994 | US5322936 Nucleic acids encoding trypanosoma cruzi heparin-binding protein |
| 06/21/1994 | US5322931 Reacting in polar solvent in presence of a dehydrating agent and activating agent |
| 06/21/1994 | US5322926 Thrombin inhibitors |
| 06/21/1994 | US5322839 Protein fraction for cosmetic and dermatology care of the skin |
| 06/21/1994 | US5322838 Use of INHIB (the C3 β-chain) in the detection and inhibition of inflammation |
| 06/21/1994 | US5322837 Stimulating production of red blood cells |
| 06/21/1994 | US5322836 Bioactive agents, compositions and materials comprising said bioactive agents |
| 06/21/1994 | US5322777 Administering for bacterial infections; obtained from culture of Planobispora rosea ATCC 53773 |
| 06/21/1994 | US5322776 DNA sequences encoding phospholipase A2 enzyme and processes for producing enzyme |
| 06/21/1994 | US5322693 Lactoneotrehalose, and its preparation and uses |
| 06/21/1994 | US5322678 Alteration of pharmacokinetics of proteins by charge modification |
| 06/21/1994 | CA2002343C Tailored beta-prime stable triglyceride hardstock |
| 06/21/1994 | CA1330304C Tissue irrigating solution |
| 06/21/1994 | CA1330302C Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use |
| 06/21/1994 | CA1330301C Stabilised human protein preparations |
| 06/21/1994 | CA1330300C Pharmaceutical preparation for therapy of immunodeficit states |
| 06/21/1994 | CA1330299C Composition of anticoagulants |
| 06/21/1994 | CA1330298C Preparations for preventing adhesions of organs and parts of organs |
| 06/21/1994 | CA1330295C Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas |